FIELD: organic chemistry, steroids, medicine, chemical-pharmaceutical industry.
SUBSTANCE: invention relates to an agent exhibiting structure 7β-hydroxyepiandrosterone or 7β-dehydroepiandrosterone, or their pharmaceutically acceptable esters of the structural formula (I) 
used for protection of neurons against their damages. Compounds elicit high effectiveness and bioavailability.
EFFECT: valuable medicinal properties of compounds.
15 cl, 3 dwg, 3 tbl, 22 ex
| Title | Year | Author | Number |
|---|---|---|---|
| PREVENTIVE AND THERAPEUTIC HYDROXIDE APPLICATION | 2002 |
|
RU2329049C2 |
| 7-HYDROXYEPIANDROSTERON WITH NEUROPROTECTIVE ACTIVITY | 2001 |
|
RU2307654C2 |
| PROSTAGLANDIN/CYCLOOXYGENASE PATHWAY MODULATION | 2007 |
|
RU2448712C2 |
| METHODS FOR EPLERENONE OBTAINMENT | 2003 |
|
RU2339642C9 |
| NEW OXIME CHOLEST-4-EN-3-ONE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, AND METHOD FOR PREPARING | 2009 |
|
RU2496784C2 |
| TRICYCLIC CYTOPROTECTIVE COMPOUNDS | 2006 |
|
RU2404967C2 |
| STEROIDAL NITRONES FOR TREATMENT AND PREVENTION OF CEREBRAL STROKE OR ISCHEMIA, ALZHEIMER'S AND PARKINSON'S DISEASE AND AMYOTROPHIC LATERAL SCLEROSIS | 2014 |
|
RU2668514C2 |
| TRANSDERMAL STEROID COMPOSITIONS | 2005 |
|
RU2371183C2 |
| 17-DEOXY-1,3,5-(10)-ESTRATRIENE, METHODS FOR TREATMENT, METHOD FOR SYNTHESIS OF 7-ALPHA-METHYLESTRONE, COMPOUNDS, PHARMACEUTICAL COMPOSITION | 1998 |
|
RU2233288C2 |
| NMDA RECEPTOR MODULATORS AND USING THEM | 2009 |
|
RU2515615C2 |
